Trial Profile
A single arm, open label study for evaluation the effect and saft of Chidamide in the treatment of HBV positive diffuse large B cell lymphoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2018
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 20 Aug 2018 New trial record